Ayuda
Ir al contenido

Dialnet


II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina

    1. [1] Pontificia Universidad Católica de Chile

      Pontificia Universidad Católica de Chile

      Santiago, Chile

    2. [2] Universidad de Chile

      Universidad de Chile

      Santiago, Chile

    3. [3] Universidad de La Frontera

      Universidad de La Frontera

      Temuco, Chile

    4. [4] Clínica Las Condes

      Clínica Las Condes

      Santiago, Chile

    5. [5] Universidad Autónoma de Chile

      Universidad Autónoma de Chile

      Temuco, Chile

    6. [6] Universidad Católica del Maule

      Universidad Católica del Maule

      Provincia de Talca, Chile

    7. [7] Hospital San Juan de Dios

      Hospital San Juan de Dios

      Santiago, Chile

    8. [8] Hospital de la Dirección de Previsión de Carabineros de Chile Unidad de Diabetes Servicio de Medicina
    9. [9] Hospital San Borja Arriarán Servicio de Endocrinología y Diabetes
  • Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 143, Nº. 5, 2015, págs. 637-650
  • Idioma: español
  • Títulos paralelos:
    • Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance
  • Enlaces
  • Resumen
    • Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.

Los metadatos del artículo han sido obtenidos de SciELO Chile

Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno